Racial Variations in COVID-19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti-Androgens a Potential Treatment for COVID-19?

    April 2020 in “ Journal of Cosmetic Dermatology
    John D. McCoy, Carlos Gustavo Wambier, Sergio Vano-Galvan, Jerry Shapiro, Rodney Sinclair, Paulo Müller Ramos, Kenneth Washenik, Murilo Ferreira de Andrade, Sabina Herrera, Andy Goren
    Image of study
    TLDR Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.
    The article suggests that genetic variations in the androgen receptor may be a contributing factor to the racial disparities in COVID-19 deaths. The authors propose that androgens may be implicated in COVID-19 disease severity and that special attention may need to be given to African Americans infected with the virus. The article suggests that anti-androgens or androgen modulating drugs may be beneficial in treating COVID-19, particularly if androgen sensitivity can be confirmed as a predisposition to SARS-Cov-2 disease severity.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results
      Medical Remedies for Alopecia

      research Medical Remedies for Alopecia

      December 2024 in “Research Journal of Topical and Cosmetic Sciences”
      Natural treatments for alopecia are gaining interest due to fewer side effects.
      COVID-19 Pandemic: What About the Gonads?

      research COVID-19 Pandemic: What About the Gonads?

      9 citations, March 2021 in “Hormones”
      COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.
      Dermatologic Manifestations of Polycystic Ovary Syndrome

      research Dermatologic Manifestations of Polycystic Ovary Syndrome

      76 citations, January 2007 in “American Journal of Clinical Dermatology”
      Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research 2015

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.